Crossmark

Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)

Crossref DOI link: https://doi.org/10.1007/s13300-017-0274-3

Published Online: 2017-06-23

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsumura, Mihoko

Nakatani, Yuki

Tanka, Seiichi

Aoki, Chie

Sagara, Masaaki

Yanagi, Kazunori

Suzuki, Kunihiro

Aso, Yoshimasa
License Information

Text and Data Mining valid from 2017-06-23
More Information

Article History

Received: 14 March 2017

First Online: 23 June 2017

Change Date: 23 October 2017

Change Type: Erratum

Change Details: Unfortunately, the original publication of this paper contained errors in the presentation of Fig. 2.

Updates are available Erratum dated 2017-10-23

Click to view Erratum: https://doi.org/10.1007/s13300-017-0308-x